Studies

  1. Adalimumab in paediatric CD

  2. Glutamine and whey protein improve intestinal permeability and morphology in patients with Crohn’s disease: a randomized controlled trial

  3. Cyclosporin vs infliximab in ASUC

  4. Basiliximab does not increase efficacy of corticosteroids in patients with steroid-refractory ulcerative colitis

  5. Adalimumab, azathioprine or 5ASA in postoperative recurrence in CD

  6. Adalimumab in patients with CD from Japan

  7. A randomised, double-blind, sham-controlled study of granulocyte/monocyte apheresis for moderate to severe Crohn’s disease